251 related articles for article (PubMed ID: 18462236)
1. Chemo-radiotherapy: an alternative to surgery for squamous cell carcinoma of the rectum--report of six patients and literature review.
Rasheed S; Yap T; Zia A; McDonald PJ; Glynne-Jones R
Colorectal Dis; 2009 Feb; 11(2):191-7. PubMed ID: 18462236
[TBL] [Abstract][Full Text] [Related]
2. Squamous-cell carcinoma of the rectum: a rare but curable tumor.
Nahas CS; Shia J; Joseph R; Schrag D; Minsky BD; Weiser MR; Guillem JG; Paty PB; Klimstra DS; Tang LH; Wong WD; Temple LK
Dis Colon Rectum; 2007 Sep; 50(9):1393-400. PubMed ID: 17661147
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors in combined radiochemotherapy of the anal canal carcinoma].
Schneider I; Grabenbauer G; Matzel K; Sauer R; Hohenberger W
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1426-8. PubMed ID: 9931901
[TBL] [Abstract][Full Text] [Related]
6. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862
[TBL] [Abstract][Full Text] [Related]
7. Treatment of primary rectal squamous cell carcinoma by primary chemoradiotherapy: should surgery still be considered a standard of care?
Clark J; Cleator S; Goldin R; Lowdell C; Darzi A; Ziprin P
Eur J Cancer; 2008 Nov; 44(16):2340-3. PubMed ID: 18707873
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiotherapy in the management of primary squamous-cell carcinoma of the rectum.
Wang ML; Heriot A; Leong T; Ngan SY
Colorectal Dis; 2011 Mar; 13(3):296-301. PubMed ID: 20002695
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiation therapy for squamous cell carcinoma of anal canal cancer: report of a case.
Ando H; Nishimura T; Nakamura T; Sugimura H; Nakamura S
Radiat Med; 2000; 18(3):199-203. PubMed ID: 10972551
[TBL] [Abstract][Full Text] [Related]
10. Combined chemoradiotherapy for locally advanced squamous cell carcinoma of the bulbomembranous urethra: a case report.
Lutz ST; Huang DT
J Urol; 1995 May; 153(5):1616-8. PubMed ID: 7714987
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
Ferrandina G; Macchia G; Legge F; Deodato F; Forni F; Digesù C; Carone V; Morganti AG; Scambia G
Oncology; 2008; 74(1-2):42-9. PubMed ID: 18544959
[TBL] [Abstract][Full Text] [Related]
12. Size does matter: can we reduce the radiotherapy field size for selected cases of anal canal cancer undergoing chemoradiation?
Crowley C; Winship AZ; Hawkins MA; Morris SL; Leslie MD
Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):376-9. PubMed ID: 19282157
[TBL] [Abstract][Full Text] [Related]
13. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
Micke O; Bruns F; Schäfer U; Prott FJ; Willich N
Anticancer Res; 2005; 25(3A):1663-6. PubMed ID: 16033078
[TBL] [Abstract][Full Text] [Related]
14. [Squamous cell carcinoma of the canal anal].
Guimarães AP; Matos D; Segreto R; Forones NM
Arq Gastroenterol; 2001; 38(1):9-13. PubMed ID: 11582966
[TBL] [Abstract][Full Text] [Related]
15. [Concurrent chemoradiotherapy for squamous cell carcinoma of the anal canal-report of four cases].
Kinjo A; Ogawa K; Iraha S; Tamaki W; Toita T; Kakinohana Y; Samura H; Kinjo I; Nishimaki T; Kuniyoshi Y; Murayama S
Gan To Kagaku Ryoho; 2008 Mar; 35(3):519-22. PubMed ID: 18347409
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of surgical resection after induction chemotherapy for patients with T4b squamous cell head and neck cancer.
Rivera F; Eugenia Vega-Villegas M; López C; Francisca López-Brea M; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Hinojo C; Márquez R; Angel Alonso-Bermejo M; Salcedo M; Blanco Y; Vega N; López-Tarruella S; Sanz-Ortiz J
Acta Oncol; 2008; 47(8):1584-9. PubMed ID: 18607841
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma of the hypopharynx: single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches.
Gupta T; Chopra S; Agarwal JP; Laskar SG; D'cruz AK; Shrivastava SK; Dinshaw KA
Acta Oncol; 2009; 48(4):541-48. PubMed ID: 18979267
[TBL] [Abstract][Full Text] [Related]
18. Effect of body mass index on chemoradiation outcomes in head and neck cancer.
McRackan TR; Watkins JM; Herrin AE; Garrett-Mayer EM; Sharma AK; Day TA; Gillespie MB
Laryngoscope; 2008 Jul; 118(7):1180-5. PubMed ID: 18475213
[TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinoma of the oral tongue: a 25-year, single institution experience.
Mosleh-Shirazi MS; Mohammadianpanah M; Mosleh-Shirazi MA
J Laryngol Otol; 2009 Jan; 123(1):114-20. PubMed ID: 18588737
[TBL] [Abstract][Full Text] [Related]
20. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
